Join These Investor Panelists at Digital RESI June

20 May

By Joey Wong, Investor Research Analyst, LSN

Digital Redefining Early Stage Investment (RESI) Conference, June 8-10, takes place in just a few weeks! The Life Science Nation (LSN) investor research team has been busy organizing six exciting panels focusing on different investor groups, from big pharma, corporate venture capital, to family offices and angel investors, etc. During these panels, active life science investors will share their insight and provide tactical advice on outreach, positioning, and building the right relationships to move products forward. The goal is to facilitate constructive conversations between investors and fundraising CEOs, and provide insights on how companies can raise capital and acquire partnerships effectively.

Another exciting part of the upcoming conference is the Innovator’s Pitch Challenge, where investors and industry experts are invited to participate in the live Q&A sessions to give feedback and ask questions to the pitching companies.

If you are interested in meeting these investor panelists and pitch judges, register here for Digital RESI June! Partnering is open, but there is still time to sign up!

For those who have already registered, we highly recommend you to join the panels that are relevant to your company; you can RSVP for any panels in the partnering system to block off your meeting schedule.

Here are some of the investors who will be joining our panels and pitch sessions at Digital RESI June:

Hamzeh Abdul-Hadi
Hikma Ventures
Brent Ahrens
General Partner
Canaan Partners
Faz Bashi
Member of BOD
Life Science Angels
Attila Bérces
Brian Bronk
Head of External Innovation, Rare Diseases
Hannah Chang
Managing Director
Wu Capital
Elizabeth Cho-Fertikh
Co-Founder & Managing Director
Meda Angels
Chris Church
Associate Director, Search & Evaluation, CVRM
Juan Cueva
Senior Associate
Action Potential Venture Capital
Geoff Dacosta
Director, Business Development and Licensing
Ben Evans
Managing Director
InHealth Ventures
Naomi Fried
Managing Director & Co-Founder
Ambit Health Ventures
Robert Garber
7wire Ventures
Miles Gerson
Takeda Ventures
Sam Goldberger
Co-Founder & Managing Partner
Ambit Health Ventures
Sherry Grisewood
Senior Investment Officer
FoxHill Asset Management
Bryan Grulke
Volcano Capital
Eric Heinz
Director, Business Development (M&A)
Smith & Nephew
Merom Klein
Entrepreneur Mentor
Keiretsu Forum
Marc Martin-Casas
Seed Investments & Development
Illumina Accelerator
Andy Merken
Partner, Corporate and Securities Co-Chair, Life Sciences
Burns & Levinson
Brian Meshkin
Managing Partner, Profound Ventures Partner, Cancer Fund
Profound Ventures
Petra Meyer
Managing Director – HealthCare Sector Group Lead
Golden Seeds
Junaid Mian
Managing Partner & Longevity Lead
Nicholas Mourlas
Senior Director, New Ventures
Johnson & Johnson Innovation
Ashley Ng
McKesson Ventures
John Parker
Founder & Managing Director
Springhood Ventures
Richard Proscia
Senior Associate
Providence Ventures
Meghana Rao
Senior Manager, New Venture Transactions
Johnson & Johnson Innovation
Nadav Shimoni
Head, Digital Health
Arkin Holdings Ltd
Yaniv Sneor
Founding Member
Mid Atlantic Bio Angels
Jill Sorensen
Chief Operating Officer
Medical Technology Enterprise Consortium (MTEC)
Eran Steinberg


Imaging Arts

Ben Sun
Sand Hill Angels
Anna Turetsky
Principal, Venture Investments
The Mark Foundation for Cancer Research (MFCR)
Thomas Vogelsong
Investor/Life Science Advisor
KYTO Technology and Life Science
Scott Weiner
Amzak Health
Tim Xiao
Delos Capital
John Yianni
Managing Partner

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: